key: cord-0745629-6b2fr1j8
authors: Lecler, Augustin; Cotton, François; Lersy, Francois; Kremer, Stéphane; Héran, Françoise
title: Abnormal MRI findings of the orbital or visual pathways in patients with severe COVID-19: observations from the French multicenter COVID-19 cohort
date: 2021-07-17
journal: J Neuroradiol
DOI: 10.1016/j.neurad.2021.07.004
sha: 2dde495a5033e4c3ffb0101546ca09f9a169ed9b
doc_id: 745629
cord_uid: 6b2fr1j8

OBJECTIVES: COVID-19 is a multisystemic disease. Ophthalmological abnormalities are relatively rare among COVID-19-infected patients. The aim of our study was to report orbital and visual pathways MRI findings in a nationwide multicenter cohort of patients with severe COVID-19. METHODS: This IRB-approved retrospective multi-center study included participants presenting with severe COVID-19, who underwent brain MRI from March 4(th) to May 1(st) 2020. Two neuroradiologists (“blinded”), blinded to all data, individually analyzed morphological MRIs focusing on the orbits and the visual pathways. A second consensus reading session was performed in the case of disagreement between both readers. Clinical and ophthalmological data were compared to MRI findings. Descriptive statistical analysis and interobserver agreement for MRI reading using non-weighted Cohen kappa statistics were performed. RESULTS: 129 participants (43 [33%] women and 86 [67%] men, mean age 63 ± 14 years) were included in the study. 17/129 (13%) patients had abnormal MRI findings of the orbit or visual pathways. 11/17 (65%) patients had a FLAIR-WI hyperintense optic disc. 6/17 (35%) patients had abnormal signal of at least one of the visual pathway structures: 6/6 (100%) of the optic nerve, 1/6 (17%) of the optic chiasm, 2/6 (33%) of the optic tract and 1/6 (17%) of the optic radiations. CONCLUSIONS: Our study showed that a substantial number of patients with severe COVID-19 presented with abnormal MRI findings of the orbit or visual pathways, which might lead to potentially severe visual impairment.

(SARS-CoV-2). When symptomatic, COVID-19 is typically known to present with systemic and respiratory manifestations [1, 2] . Increasing data suggest multiorgan involvement with various organs negatively affected, such as the central nervous system [3] [4] [5] [6] [7] [8] .

Although the main mode of SARS-CoV-2 transmission is through the respiratory route, several studies have shown that ocular tissues and fluids might be an alternative mode of contamination.

Exposure of unprotected eyes to the virus may also lead to infection [9, 10] .

COVID-19 has been reported to be associated with ophthalmological abnormalities, such as conjunctivitis, chemosis, retinopathy or optic neuritis [11] [12] [13] [14] [15] . These findings are relatively rare among COVID-19-infected patients, ranging from 2 to 32% [14] [15] [16] [17] [18] . Only a few MRI studies reported orbital and/or visual pathways abnormalities in patients with severe COVID-19 [19] [20] [21] [22] [23] [24] . Among them, the French Society of Neuroradiology (SFNR) reported ocular (i.e. involving the eyeball only) MRI abnormalities from patients with severe COVID-19 from 16 hospitals including 11 university hospitals and 5 general hospitals [24] .

The aim of our study was to complete this analysis by reporting orbital (excluding ocular findings) and visual pathways MRI findings in the same nationwide multicenter cohort of patients with severe COVID-19.

This retrospective observational multicenter study was initiated by the French Society of Neuroradiology (SFNR). It included clinical and imaging data of patients from 16 hospitals including 11 university hospitals and 5 general hospitals. The study was approved by the ethical committee of Strasbourg University Hospital (CE-2020-37) and was in accordance with the 1964 Helsinki Declaration and its later amendments. Due to the emergency in the context of the COVID-19 pandemic, signed informed consent was waived. This study follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Exclusion criteria were: (i) patients with missing or non-contributory data regarding orbital or brain MRI, such as a lack of sequences or too numerous artifacts.

Clinical and ophthalmological data, such as that from visual acuity testing, fundoscopy, visual field, fluorescein angiography, and optical coherence tomography (OCT) were extracted from the patients' electronic medical records.

Quantitative real-time RT-PCR tests for SARS-CoV-2 nucleic acid were performed on nasopharyngeal or lower respiratory tract swabs and cerebrospinal fluid. Primer and probe sequences targeted two regions on the RdRp gene and were specific to SARS-CoV-2. Assay sensitivity was around 10 copies/reaction (in house-method, Institut Pasteur, Paris, France).

Imaging studies were conducted either on 1.5-or 3-Tesla MRI. The multicenter nature of the study and the various clinical setups did not allow standardization of sequences. The most frequent sequences performed were 3D T1 weighted spin-echo MRI with and without contrast enhancement, diffusion-weighted imaging, gradient-echo T2 or Susceptibility-weighted imaging, and 2D or 3D FLAIR-WI after administration of gadolinium-based contrast agent.

System (General Electric, Milwaukee, WI, USA) of a single core center.

Two neuroradiologists with 9 years ("blinded") and 30 years ("blinded") of experience in ophthalmological imaging, blinded to all data, individually read anonymized MR images on a dedicated workstation. A second consensus reading session was performed in case of disagreement between both readers.

The readers assessed the presence of abnormal morphology, signal or enhancement of the following structures for each patient:

• The orbit including the extraocular muscles, the orbital fat, the lacrimal gland.

• The visual pathways including the optic disc and optic nerve, the optic chiasm, the optic tract and the optic radiations. Normal-appearing white matter was used as a reference to assess abnormal signal changes.

The analysis of ocular (i.e. eyeball) structures have already been reported in a previous publication [24] . Therefore, they were not analyzed for this study.

Quantitative variables are presented as mean, standard deviation or median, interquartile range (IQR), and categorical variables as percentages. Interobserver agreement for the MRI reading was assessed using non-weighted Cohen kappa statistics and interpreted as follows: 0.0 to 0.2, poor correlation; 0.21 to 0.4, fair correlation; 0.41 to 0.6, moderate correlation; 0.61 to 0.8, good correlation; and 0.81 to 1, almost perfect correlation. Data were analyzed using the R software package version 3.6.1. 

No patient had signal abnormality of the extraocular muscles, the orbital fat or the lacrimal glands.

11/17 (65%) patients had a FLAIR-WI hyperintense optic disc (figure 2). 6/17 (35%) patients had abnormal signal on FLAIR-WI of at least one of the visual pathway structures: 6/6 (100%) of the optic nerve, 1/6 (17%) of the optic chiasm, 2/6 (33%) of the optic tract and 1/6 (17%) of the optic radiations ( figure 3 and 4) . Detailed imaging characteristics are displayed in Table 2 .

None of the patients with FLAIR-WI hyperintense optic disc underwent fundoscopy. 1/6 (17%) patients with abnormal FLAIR-WI signal of at least one of the visual pathway structures had an ophthalmological examination, which was unremarkable. 

Our study showed that a substantial number of patients with severe COVID-19 presented with abnormal MRI findings of the orbit or visual pathways. To the best of our knowledge, our study is the first large multicenter series to date to report these findings.

We showed that 13% of our patients presented with at least one MRI signal abnormality of the orbit or the visual pathways. This rate is substantially higher than the prevalence of 5.5% of ocular manifestations among COVID-19 patients reported in a recent meta-analysis [14] . It might be explained by the inclusion of patients with severe COVID-19 in our series, who are more atrisk to develop ocular manifestations related to COVID-19 [15, 25, 26] , and by the analysis of retro-ocular structures on MRI which were not analyzed in previous ophthalmological series. 65% of our patients had FLAIR-WI hyperintense optic discs, almost always bilateral, with no enhancement after gadolinium injection. Only one patient underwent fundoscopy, showing no optic disc abnormality. 35% of our patients presented with FLAIR-WI high signal abnormalities of at least one of the visual pathways structures, mostly a unilateral high signal intensity of the optic nerve. One patient had striking bilateral extensive involvement of the optic nerves, optic chiasm, optic tracts and optic radiations. There was no enhancement after contrast injection. Only one of these patients underwent fundoscopy showing no ocular abnormality. The prevalence of visual pathway structures abnormalities is surprisingly high in our series, given that no increase in the incidence of ischemic or inflammatory optic neuropathies cases related to COVID-19 has been reported in the literature yet. Only a few cases of optic neuritis in association with a COVID-19

infection have been reported in the literature so far, probably due to an immune response triggered by viral antigens rather than being a direct consequence of the infection [11] [12] [13] 23] . As opposed to cases reported in the literature, none of our patients had brain MRI abnormalities suggestive of associated demyelinating disease.

The origin of the various MRI abnormalities that we described in our series remains unknown.

Human and animal coronaviruses were reported to cause inflammation of varying ocular segments, causing retinitis, choroiditis, retinal detachment or optic neuritis in the literature [27] [28] [29] . To explain retinal or optic nerve damage a wide variety of mechanisms has been described, such as direct infiltration of the retina and retina pigment epithelium by the virus, vasculitis, or autoimmune process, the latter mechanism being most frequent [27, 28] .

Our study advocates for a dedicated exploration of the orbit and the visual pathways in all patients presenting with severe COVID-19. Severe eye problems might go largely unnoticed as these patients are hospitalized in intensive care units under sedation. Our data support the need for an ophthalmological evaluation and follow-up of these patients to improve the management of potentially severe, negative ophthalmological outcomes and to provide appropriate treatment.

Our study suffers from several limitations. Firstly, it is a retrospective study with a limited number of patients and non-optimized MRI protocols. Secondly, ophthalmological data were not available for most of our patients, due to the severity of their disease. Thirdly, we lacked followup MRI and clinical evaluation. Fourthly, we did not have a control group of critically ill patients hospitalized in intensive care unit without COVID-19 infection. Therefore, we cannot be certain that the MRI abnormalities we reported in our study were related to COVID-19 infection.

Our study showed that a substantial number of patients with severe COVID-19 infection presented with abnormal MRI findings of the orbit or visual pathways, which might lead to potentially severe visual impairments. Table 2 Clinical and imaging characteristics of patients presenting with abnormal MRI findings of the orbit or visual pathways.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study

Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study

Retrospective Observational Study of Brain MRI Findings in Patients with Acute SARS-CoV-2 Infection and Neurologic Manifestations

COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features

Neurologic Features in Severe SARS-CoV-2 Infection

Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?

2019-nCoV transmission through the ocular surface must not be ignored

Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19

Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report

Multiple sclerosis following SARS-CoV-2 infection

The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid

Characteristics of Ocular Findings of Patients With Coronavirus Disease

Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: A cross-sectional study

Ocular manifestation, comorbidities, and detection of severe acute respiratory syndrome-coronavirus 2 from conjunctiva in coronavirus disease 2019: A systematic review and meta-analysis

Ocular Features and Associated Systemic Findings in SARS-CoV-2 Infection

Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19

Rhino-Orbital Mucormycosis Associated With COVID-19

The Spectrum of Neuroimaging findings on CT and MRI in Adults with Coronavirus Disease (COVID-19)

Complications of Orbital Emphysema in a COVID-19 Patient

COVID-19-Induced Acute Bilateral Optic Neuritis

Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study

Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran

Conjunctivitis and COVID-19: A meta-analysis

Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals

Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy